A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders

  title={A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders},
  author={G. Sanacora and M. Frye and William McDonald and S. Mathew and M. S. Turner and A. Schatzberg and P. Summergrad and C. Nemeroff},
  journal={JAMA Psychiatry},
  • G. Sanacora, M. Frye, +5 authors C. Nemeroff
  • Published 2017
  • Medicine
  • JAMA Psychiatry
  • Importance Several studies now provide evidence of ketamine hydrochloride’s ability to produce rapid and robust antidepressant effects in patients with mood and anxiety disorders that were previously resistant to treatment. Despite the relatively small sample sizes, lack of longer-term data on efficacy, and limited data on safety provided by these studies, they have led to increased use of ketamine as an off-label treatment for mood and other psychiatric disorders. Observations This review and… CONTINUE READING
    190 Citations

    Topics from this paper

    Use of Ketamine in Clinical Practice: A Time for Optimism and Caution.
    • 10
    Ketamine for Depression, 2: Diagnostic and Contextual Indications.
    • C. Andrade
    • Psychology, Medicine
    • The Journal of clinical psychiatry
    • 2017
    • 12
    • PDF
    Ketamine: A Review for Clinicians.
    • 4
    • PDF
    Ketamine for the Treatment of Depression.
    • 2
    Role of Ketamine in Severe Depression with suicidal ideation - Insights from a Case Study.
    • 4


    Ketamine administration in depressive disorders: a systematic review and meta-analysis
    • 217
    • PDF
    Is Off-label repeat prescription of ketamine as a rapid antidepressant safe? Controversies, ethical concerns, and legal implications
    • 29
    • PDF
    Ketamine safety and tolerability in clinical trials for treatment-resistant depression.
    • 118
    • PDF
    Ketamine use: a review.
    • 366
    • PDF
    Ketamine and other glutamate receptor modulators for depression in adults.
    • 115
    Antidepressant effects of ketamine in depressed patients
    • 2,323
    • PDF
    Psychiatric safety of ketamine in psychopharmacology research
    • 102
    • PDF
    Effects of Low-Dose and Very Low-Dose Ketamine among Patients with Major Depression: a Systematic Review and Meta-Analysis
    • 119
    • PDF